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Background: In young children, it is difficult to obtain a reproducible flow-volume curve
throughout all stages of bronchial challenge. The forced oscillation technique (FOT) is espe-
cially established in paediatrics because this method does not require forced or maximal
manoeuvres and is less cooperation-dependent than conventional spirometry.
Objectives: To evaluate the association of spirometric and impulse oscillometric (IOS) indices
in a short protocol for methacholine provocation.
Methods: The primary endpoint was the methacholine dose that caused a 20% decrease in FEV1
(PD20FEV1) compared to baseline. Changes in respiratory resistance (Rrs5) and reactance
(Xrs5) acquired by IOS were compared with FEV1.
Results: Forty-eight children (5.3  0.9 years) were challenged. The mean maximal reduction
in FEV1 was 29.8%  14.7 (p < 0.0001), the mean increase in Rsr5 was 55.3%  31.7, and the
mean decrease in Xrs5 was 0.37 kPa s L1  0.23 (p < 0.001). An increase in Rrs5 of 45.2% and
a decrease in Xrs5 of 0.69 kPa s L1 showed the optimal combination of sensitivity and speci-
ficity to detect a 20% reduction in FEV1 (0.72 and 0.73; 0.80 and 0.76, respectively), and the
area under the ROC curve was 0.76 and 0.81, respectively (p < 0.005). In 28 patients with
significant changes in FEV1 and Rsr5, the PD20FEV1 was 0.48 mg methacholine 0.59 and
the PDþ40Rrs5 was 0.28 mg methacholine 0.45 (p Z 0.03).
Conclusions: A short protocol for methacholine challenge testing is feasible in young children.
IOS detected 70e80% of patients who responded in spirometry. During the challenge, the Rrs5
response preceded the FEV1 response.
ª 2012 Elsevier Ltd. All rights reserved.6301 5381; fax: þ49 69 6310 6061.
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Age [yrs, mean  SD] 5.3  0.9
Weight [kg, mean  SD] 21.5  4.2
Height [cm, mean  SD] 114.9  7.9
BMI [kg (m2)1, mean  SD] 16.2  1.9
FVC [% pred. mean  SD] 91.2  16.3
z-scores FVC male [mean  SD] 0.08  2.96
female [mean  SD] 0.35  1.3
FEV1 [% pred. mean  SD] 107.7  20.0
z-scores FEV1 male [mean  SD] 1.15  2.89
female [mean  SD] 0.57  1.28Bronchial pharmacological provocation tests, e.g., meth-
acholine challenge testing (MCT), in young children are
usually based on ATS recommendations,1 particularly the
2-min tidal breathing method2 and the five-breath dosim-
eter method3 (both methods were successfully adapted to
preschool children). Nine studies have investigated the
tidal breathing method,4e12 and six studied the dosimeter
method.13e18 However, these studies were quite variable
regarding the primary outcome parameter, duration of
inhalation, delivered volume, number of inhalations, and
the increase in concentration between steps.
New commercially available dosimeter units in combi-
nation with safe short protocols are emerging and offer
a promising alternative to ATS recommended protocols. The
Aerosol Provocation System (APS with MedicAid sidestream
nebuliser, CareFusion, Hoechberg, Germany) combines the
advantages of the tidal breathing and five-breath protocols.
In recently published papers, Merget et al.19 and our
group20 have shown the practical use of the APS in young
adults. In comparison to the five-breath dosimeter method,
the cumulative dose of 1 mg methacholine was equal to
a concentration of 8 mg/mL methacholine as the usually
accepted cut-off point of bronchial hyperresponsiveness
(BHR).20 In a former study, Hagmolen of Have et al.21
showed the repeatability of the APS method in 22 chil-
dren aged 7e14 years. Two consecutive methacholine
challenge tests revealed good agreements due to a strong
intraclass correlation (ICC 0.91) and good repeatability, as
measured by the method of Bland and Altman.
The sensitivity of the MCT depends on the investigated
population. The most common clinical indication is to
evaluate the likelihood of asthma in patients in whom the
diagnosis is suggested by current symptoms but is not
obvious. From an epidemiological standpoint, the proba-
bility of asthma is equal to the prevalence of asthma. When
a patient presents with symptoms of asthma the probability
is much higher, e.g., between 30 and 70%. Depending on the
degree of the bronchial hyperresponsiveness, the post MCT
likelihood of asthma might be roughly 90e98%.1 In 135
children and young adults with asthma the sensitivity of
MCT in detecting bronchial hyperresponsiveness (at or
below 8 mg/mL) was 98% and methacholine was a better
discriminating challenge between severity groups than the
adenosine monophosphate or exercise challenges.22
It is difficult to obtain a reproducible flow-volume curve
throughout all stages of bronchial challenge in young chil-
dren, and there is an ongoing debate about the best
outcome parameter.23 The impulse oscillation system (IOS)
(CareFusion, Hoechberg, Germany) and forced oscillation
technique (FOT) do not require patients’ efforts and may
be useful in testing patients who cannot perform accept-
able spirometry manoeuvres. The correlation between
a 20% decrease in FEV1 and changes in Rrs has shown that
the threshold for a positive test is greater than a 35e40%
increase in resistance. An increase in Rrs of less than
35e40% of baseline at the highest dose applied can be
considered a negative test.23 However, the IOS is different
from the classical FOT because an impulse (a rectangular
wave form) rather than a pseudorandom noise signal(a mixture of several sinusoidal wave forms) is applied by
cessing. Especially at lower frequencies Rrs IOS was slightly
greater than Rrs FOT, whereas Xrs IOS and Xrs FOT were
very similar.24
In the present study, we investigated a short protocol for
MCT in young children. After initial pulmonary function
testing, children were challenged with incremental doses
of methacholine. The primary endpoint was the dose that
caused a 20% reduction in FEV1 compared to baseline
(PD20FEV1). We compared the results of the reduction in
FEV1 with the airway resistance (Rrs5) and reactance (Xrs5)
at a 5-Hz oscillatory frequency.
Materials and methods
Subjects
Children aged 3e6 years attending the outpatient clinic
were recruited into the study. All children had a history of
recurrent wheezing, at least two episodes with coughing
that lasted longer than six weeks, and a diagnosis of
recurrent bronchitis, viral-induced wheezing, or allergic
asthma. Short-acting beta-agonists were withdrawn 8 h,
long-acting beta-agonists 48 h, leukotriene receptor
antagonists 24 h, and inhaled corticosteroids 7 days before
MCT. The subjects’ baseline characteristics are summarised
in Table 1. The study was approved by the Ethics
Committee of Goethe-University, and informed consent was
obtained from the participants’ parents prior to the start of
the study.
Study design
This was an unblinded, cross-sectional study consisting of
one visit. For baseline measurements first impulse oscill-
ometry and after that spirometry (MasterScreen, Care-
Fusion, Germany) measurements were repeated up to five
times, and three manoeuvres performed with each method
were recorded. Children were to produce at least three
acceptable IOS measurements and three acceptable
flow volume loops (FVL), with the second highest FVC and
FEV1 being within 0.1 L or 10% of the highest value.
23
Methacholine challenge in young children 629Consecutive MCT was performed in children with successful
cooperation in pulmonary function. At each inhalation step
a single oscillometry and spirometry was performed. After
the challenge procedure, patients received one to three
puffs of Salbutamol (0.1 mg) until the FEV1 returned to at
least 90% of the baseline value.
Forced oscillation technique
The FOT is especially established in paediatrics because
this method does not require forced or maximal manoeu-
vres and is less cooperation-dependent than conventional
spirometry. One of the latest oscillometric technologies is
the Impulse Oscillometry System (IOS, CareFusion, Hoech-
berg, Germany).
During tidal breathing, the airflow of the subject under
investigation was superimposed by small artificial pressure
impulses produced by a loudspeaker generator. The
advantage of impulse test signals is the relatively large
spectral contents, which facilitate a thorough differentia-
tion of pulmonary function.
The flow response of the respiratory system to these
pressure impulses was recorded and analysed, providing
data on the resistance of mainly conducting airways and
the reactance representing the peripheral structures of
the lung-thorax-system. From a recording of approxi-
mately 20 s, the average values of airway resistance Rrs5
and lung reactance Xrs5 at a 5-Hz signal frequency could
be derived.
Changes in Rrs values but not in Xrs values can be
expressed as percentage of baseline values. Xrs values may
be very close to zero and expression of changes in X-values
as a percentage would result in unrealistic numbers. For
this reason, only Rsr values are helpful to quantify relative
changes in individual subjects.25 All calculations regarding
the Xrs values, e.g., the ROC analysis, were made with
absolute numbers.
Methacholine challenge
MCT was performed as described previously.20 The APS
dosimeter technique (CareFusion, Hoechberg, Germany)
allows the computer-controlled production of aerosol using
a jet-type nebuliser (Sidestream, MedicAid) powered by
compressed air. The integrated pressure calibration
procedure of the compressor ensured highly constant and
reproducible nebuliser output. APS was calibrated to
produce a continuous nebuliser output of 240 mg/min.
In children, instead of impulse nebulisation, a contin-
uous nebulisation over the entire inspiratory cycle was
preferred. Subjects were to breathe gently without holding
their breath, avoidance on deep inhalations and maintain
maximal inspiratory flows below 0.5 L/s. During tidal
breathing, the system exactly and automatically deter-
mined the administered dose of methacholine. The system
measured the effective nebulisation time and determined
the cumulative dose of the required inspiratory breaths. In
continuous nebulisation mode, the inhalation time and
number of breaths were dependent upon the concentration
of the employed methacholine and ventilation of the child.
If the final cumulative dose was achieved, the nebuliserstopped immediately. Simultaneously, the flow recording
was shown on screen, visualising the flow threshold to the
patient.
The incremental protocol was slightly modified. The
doses of inhaled methacholine with a concentration of
16 mg/mL were increased according to the following
specifications (from step 1e4): 0.1, 0.4, 0.8, and 1.6 mg.
Thus, the entire protocol delivered cumulative doses of 0.1,
0.5, 1.3 and 2.9 mg. Two minutes after each inhalation,
oscillometry and spirometry were measured, and the indi-
vidual provocation dose (PD) that caused a 20% drop in FEV1
(PD20FEV1) was calculated by logarithmic interpolation
using an integrated program. In tests with a positive
response at the first step, a virtual initial dose of 0.01 mg
methacholine was assumed to calculate a provocative
dose.19
Statistical methods
Statistical analyses were performed using GraphPad Prism
5.01 (GraphPad Software, Inc.). Pulmonary function
parameters and PDs of methacholine were expressed as
the means and standard deviations (SDs). The intra-
measurement repeatability was expressed as the coeffi-
cient of variation (CV) (SDs expressed as a percentage
of the mean, i.e., 100  SDs/mean). For consecutive
measurements, the repeatability coefficient (CR) was
calculated according to the following equation: CR Z 2.83
 within-subject standard variation SDW (SDWZ division of
SDs of the difference of 2 means by the square root).
To define the sensitivity and specificity of Rsr5 and Xrs5
to detect a 20% fall in FEV1, a receiver-operating charac-
teristic (ROC) curve was plotted. Cut-off levels were opti-
mised using the Youden index (sensitivity þ specificity  1),
and the accuracy was measured by the area under the ROC
curve. In combination of Rsr5 and Xrs5 to detect a 20% fall
in FEV1 the chi-square test was used to define the sensi-
tivity and specificity. PD20FEV1 and PDþ40Rsr5 were
compared to give the cumulative dose of methacholine
required to reach the PDs. To assess whether the means of
two groups were significantly different, the student t-test
was used. Correlations between PDs were calculated using
Pearson’s correlation test. Probability (p) values  0.05
were considered statistically significant.
Results
Fifty-seven patients were included in the study. Seven
children were not able to perform adequate PFTs, and two
did not perform adequate MCTs. Forty-eight children were
successfully challenged: 29 were male and 19 female, the
mean age was 5.3  0.9 years, and the mean height was
114.9  7.9 cm. Thirteen children were diagnosed with
recurrent bronchitis, 26 with viral induced wheeze, and 9
with allergic asthma. The children were not obese as indi-
cated by the body mess index (BMI) (Table 1). Eleven of 48
patients had a positive skin prick test; 5 were mono-
sensitised against birch, grass, or mites, 4 were sensitised
against two allergens (birch and grass or birch and cat), and
2 were sensitised against multiple allergens (birch, grass,
mite, cat, horse, and moulds).
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All 48 children performed the spirometric measurements
with a forced expiratory time (FET) of greater than 1 s and
a back-extrapolated volume (VBE) of less than 80 mL or
12.5% of FVC. The mean FVC was 91.2%  16.3, and the
mean FEV1 106.2%  20.1. In three IOS measurements,
the mean, SD, and coefficient of variation (CV) for Rsr5
and Xrs5 were 0.99 kPa s L1  0.23, CV 22.7% and
0.40 kPa s L1  0.12, CV 31.0%, respectively. We compared
the between-test repeatability in two consecutive IOS
measurements, and the repeatability coefficient (CR) was
0.073 and 0.074 for Rrs5 and Xrs5, respectively.
In MCT, the time from the beginning to the end of MCTs
was 13 min, and a median of 2 step-ups (range 1e4) was
needed to achieve a significant reduction in FEV1 (Fig. 1). In
48 children, the mean maximal reduction in FEV1 was
29.8%  14.7 (p < 0.0001), the mean increase in Rrs5 was
55.3%  31.7 or 0.52 kPa s L1  0.30, and the mean
decrease in Xrs5 was 0.37 kPa s L1  0.23 (all p < 0.0001)
(Tables 2a and b). To evaluate the sensitivity and specificity
of Rrs5 and Xrs5 to detect a 20% drop in FEV1, we calculated
the receiver-operator characteristic (ROC) curve (Figs. 2
and 3). An Rrs5 increase of 45.2% compared to the base-
line showed the optimal combination of sensitivity and
specificity (0.72 [95%CI 0.54e0.86] and 0.73 [95%CI
0.45e0.92], respectively). The area under the ROC (AUC)
was 0.76 (p < 0.005). An Xrs5 decrease of 0.69 kPa s L1
showed the optimal combination of sensitivity and speci-
ficity (0.80 [95%CI 0.52e0.96] and 0.76 [95%CI 0.58e0.89],
respectively), and the AUC was 0.81 (p < 0.001). Thus, the
combination of an increase in Rsr5 45% and/or a decrease
in Xrs5 0.69 kPa s L1 showed that 39 of 48 (81%) subjects
had a significant drop in spirometry (sensitivity 0.74 [95%CI
0.67e0.84], specificity 0.76 [95%CI 0.57e0.90], positive
predictive value 0.87, negative predictive value 0.57).
Forty of the children had a significant reduction of
greater than 20% FEV1, and 33 children had a significantFigure 1 Changes from baseline (mean  SD) during incre-
mental provocation steps 1 to 4 in methacholine challenge in
n Z 40 patients with a significant fall in FEV1. Dots indicate
changes in FEV1, and squares corresponding changes in Rrs5.
“Pre” indicates baseline value of 100%; “post” indicates values
after bronchodilation.increase of greater than 40% Rsr5 as the overall accepted
cut-off for a significant increase in FOT. The mean
PD20FEV1 was 0.42 mg  0.52 methacholine, and the mean
PDþ40Rrs5 was 0.30 mg  0.43 methacholine.
We compared the PD’s of 28 patients with a significant
reaction in both measurements. In this group, the dose of
methacholine required to achieve a significant reaction was
lower in IOS compared with spirometry. The mean
PD20FEV1 was 0.48 mg  0.59 methacholine, and the mean
PDþ40Rrs5 was 0.28 mg  0.45 methacholine (p Z 0.03).
Both parameters were significantly correlated (r Z 0.65,
p < 0.001) (Fig. 4). However, in the group with a cut-off of
45% Rsr5 both parameters were approaching (n Z 22,
PD20FEV1 0.37 mg  0.46 and PDþ45Rrs5 0.32 mg  0.55
methacholine, p Z 0.39).Discussion
In the evaluation of MCT in a particular population (i.e.,
very young children), the definition of the BHR in this age
group is important. However, there are unresolved issues.
Current guidelines for MCT from the ERS and the ATS task
forces are suitable for adults and schoolchildren but not for
preschool children. Methods to assess bronchoconstriction
in preschool children have been used since the 1990s, with
an increasing number of studies in this age group, but the
knowledge is still incomplete.23 In a study that compared
the five-breath dosimeter method with our method in young
adults, a cumulative dose of 1 mg of methacholine corre-
sponded with the concentration of 8 mg/mL methacholine
as the usually accepted cut-off point of BHR.20 Thus,
reactions at lower cumulative doses than 1 mg of meth-
acholine were considered as a positive test.
Furthermore, if a new parameter for a functional test is
introduced, its distribution in the general population should
be defined. Due to ethical considerations in Germany,
healthy children below 14 years are not allowed to take part
in MCTs to define normal values. To compare two methods
and the bronchial response during MCTs, it is an advantage
to examine a potentially hyperreactive population that
represents the total range from severe BHR to normal BHR.
The measurement of changes in FEV1 is still the primary
outcome measure and gold standard for MCTs.1 However,
concerns exist whether spirometry is reproducible
throughout all stages of MCT in young children; thus, forced
oscillation techniques might be a promising alternative.23 In
a crossover study in 25 children aged 4e6 years, all children
who were able to perform reproducible measurements of
FEV1 and airway resistance completed the MCT.
13 In an
Australian birth cohort in children aged 5 to 7, MCT with
spirometry was successfully completed in 537 of 565 (95%)
of the subjects.26 In 173 children who were aged 3, 4, 5,
and 6 years, the success rate of performing MCT increased
with age (55.8%, 71.6%, 88.5%, and 96%, respectively).27 In
the present study, almost all children (48 of 50, 96%) who
performed reproducible basic pulmonary measurements
completed the MCT.
If any technique compares with a gold standard to
measure BHR, e.g., spirometry or sRaw, the results will
always favour the primary objective, and another proce-
dure will be inferior to the reference. In a comparison of
Table 2a Pulmonary function parameter total group.
Baseline Final step Bronchodilator
FVC [% pred. mean  SD] 91.2  16.3 69.3  18.7 90.3  19.4
FEV1 [% pred. mean  SD] 107.7  20.0 77.9  20.2 98.0  12.7
Rrs5 [kPa l1 s1, mean  SD] 0.96  0.23 1.48  0.40 0.90  0.21
Xrs5 [kPa l1 s1, mean  SD] 0.38  0.14 0.75  0.27 0.35  0.13
Table 2b Pulmonary function parameter responder.
Baseline Final step Bronchodilator
FVC [% pred. mean  SD] 90.8  14.4 65.7  14.3 86.9  14.8
FEV1 [% pred. mean  SD] 107.2  18.9 68.5  8.7 96.1  11.8
Rrs5 [kPa l1 s1, mean  SD] 0.98  0.23 1.50  0.40 1.05  0.17
Xrs5 [kPa l1 s1, mean  SD] 0.42  0.13 0.79  0.26 0.36  0.14
Methacholine challenge in young children 631different lung function measurements during MCT in young
children, sRaw and Xrs5 were superior to FEV1 and Rrs5 in
detecting BHR.14 However, in this study, 48 children were
screened to identify those who were capable of performing
technically satisfactory and reproducible measurements,
but only 25 of the children were included. Moreover, the
primary objective was an increase in sRaw of more than
100%. In the study by Wilson et al.28 in 19 asthmatic children
(aged 4e11 years), PtcO2 was chosen as the reference, and
only 73.4% reacted significantly in the FOT. Three of fifteen
children did not develop a 40% increase in Rrs6, and no
dose-response relationship was observed in any child.
Our primary objective was a decrease in FEV1 of 20%,
and the challenge was stopped if the patient achieved thisFigure 2 Receiver-operating characteristic (ROC) curve with
changes of Rsr5 from baseline to detect a 20% fall in FEV1. An
increase of 45% revealed the optimum cut-off, with a sensi-
tivity of 72% and a specificity of 73%. The area under the curve
(AUC) was 0.76 (p < 0.005).cut-off. Thus, patients who might have reacted with
a significant rise in Rrs5 at the next provocation step were
not included. On the other hand, five patients with a non-
significant decrease in FEV1 reacted significantly in Rsr5.
The relationship between both methods (spirometry and
IOS) is expressed by the sensitivity and specificity as well as
by the area under the roc curve (AUC). The accuracy was
good to fair and confirmed the utility and the quality of the
IOS to detect patients with BHR defined by the PD20FEV1.
Different pulmonary function parameters and different
methods of unspecific bronchial challenges have a limited
consistency. In the same individuals with signs and symp-
toms suggestive of asthma, a mannitol challenge had
a sensitivity of 68% to identify MCT positive subjects withFigure 3 Receiver-operating characteristic (ROC) curve with
results of Xsr5 to detect a 20% fall in FEV1. A value of
0.69 kPa s L1 Xrs5 revealed the optimum cut-off, with
a sensitivity of 80% and specificity of 76%. The area under the
curve (AUC) was 0.81 (p < 0.001).
Figure 4 Log10 scale of PD20FEV1 and PDþ40Rrs5
(mg methacholine) in 28 patients with a significant dual reac-
tion. (r Z 0.65, p < 0.001).
632 J. Schulze et al.a PC20 of 8 mg/mL, and methacholine had a sensitivity of
62% for identifying a mannitol positive response.29 These
data suggest that different methods measure different
aspects of BHR.
MCT will provide additional information to the usual
examinations and recommendations in children referred to
a specialised centre. Nevertheless, false negative measure-
ments will occur. During MCT, we suggest clinically moni-
toring the patients by auscultation and by signs of dyspnoea.
In cases of discrepancies between clinical presentation and
MCT, the MCT might be postponed and repeated when the
child is older and still has symptoms of asthma or BHR.
Overall, IOS and the combination of Rsr5 and Xrs5
identified young patients as having a BHR to a high degree,
and the results of Xrs5 were more sensitive compared to
Rsr5. These data provide more valid information about the
relationship of FEV1 and IOS in MCT.
In adults, deep inspirations before MCT protected non-
asthmatics from methacholine-induced bronchoconstriction
in a dose-dependent fashion but had no effect in intermit-
tent or mild persistent asthmatics.30 In another study, five
deep breaths preceding a single dose of methacholine
transiently attenuated the decreases in FEV1 and FVC in
healthy but not in mild asthmatic subjects.31 In contrast, in
asthmatics with mild airway hyperresponsiveness, deep
inhalation (dosimeter) methods produced a non-significantly
lower response in MCT than the standard tidal breathing
method.32 In vitro, in human bronchial segments from
patients without airflow obstruction tidal oscillation had no
effect on airway response to acetylcholine, whereas deep
inspiration in tidally oscillating, acetylcholine-contracted
airways produced potent bronchodilation.33
In the paediatric literature, there are few studies on the
interaction of deep inspiration and bronchial reactivity.
Because remodelling has not yet progressed to the samestage as in adults and dynamic changes of airway mechanics
may be even more influenced by breathing patterns, the
situation in children might be more interesting.34 In chil-
dren with chronic cough or asthma, when using the APS
dosimeter technique and the IOS during MCT, the Rrs was
significantly lower and the Xrs was significantly less nega-
tive after deep inhalations.35 In another paediatric study,36
which involved 4- to 7-year-old children suffering from
recurrent wheezing, the effect of deep inhalations on
respiratory impedance before and after MCT was measured
with a forced oscillation wave-tube technique. In all chil-
dren, the impedance significantly increased after MCT, and
these changes were partially reversed by deep inhalation.
The authors concluded that the deep inhalation is able to
induce changes in airway calibre that are similar to those
observed in healthy and mild asthmatics adults.
Therefore, in children, measurements with deep inha-
lation and forced expiration (e.g., spirometry) might
produce a lower number of positive patients because chil-
dren display a bronchodilation effect similar to normal or
borderline adults, whereas quiet breathing parameters
such as IOS/FOT lead to a higher number of positive tests
while avoiding the deep inhalations of forced manoeuvres.
Moreover, the effect of deep inhalation during induced
bronchoconstriction is influenced by the lung volume at
which it is determined and by volume differences due to
thoracic gas compression that occur during forced expira-
tory manoeuvres.37 The authors concluded that measuring
the maximal to partial flow ratio may result in systematic
overestimation of the bronchodilator effect of deep inha-
lation. This error is, however, relatively small (10e12%) and
may not lead to substantially erroneous conclusions.
Measuring of lung volumes presupposes body plethysmog-
raphy. The idea to combine spirometry, oscillometry and
body plethysmography in MCTs is very interesting. However,
especially in this age group, plethysmography might be
difficult, and another pulmonary function measurement
would extend the recommended time of approximately
5 min after methacholine inhalation and the effect of
methacholine would wear off.1,23
Whereas changes in FEV1 values are largely caused by
changes in airflow limitation, Rrs values are more directly
related to airway calibres.25 FEV1 is a global parameter
representing central and peripheral changes in airways.
Increasing peripheral obstruction is underestimated in
cases in which central airway resistance is increased.
Oscillometry is separated strictly between central airway
resistance (Rrs) and peripheral lung reactance (Xrs).
We showed that significant increases in Rrs5 of 40%
preceded the reactions in FEV1 at significantly lower doses
of methacholine, which is consistent with similar findings
from Vink et al.25 In 14 of 19 children aged 5e17, the
increase in resistance (especially in Rrs5) values preceded
the fall in FEV1,
25 and the authors concluded that these two
parameters reflect different pathophysiological aspects of
airway obstruction. In young children, Xrs IOS was equal to
sRAW and was more sensitive than FEV1 at detecting
changes in lung function during MCTs. The Xrs, Rrs and
sRAW but not FEV1 revealed the subclinical bronchial
obstruction prior to methacholine challenge.14 These data
suggest that apart from deep inhalation effects, oscillation
techniques are more sensitive than spirometry.
Methacholine challenge in young children 633Therefore, the IOS/FOT is an alternative in young chil-
dren, not only because oscillation techniques are more
applicable in this age group but also because these tech-
niques might have a “methacholine-sparing” effect.
However, the cumulative doses of methacholine in our
protocol were low for both methods, and an Rre5 cut-off of
a 45% vs. a 40% increase attenuated the advantage of IOS
measurements. Interestingly, we found that in young
adults, the cumulative mean dose of methacholine in our
short protocol was significantly lower compared to that of
the ATS-recommended five-breath dosimeter method.20
In 28 patients with a dual significant reaction of
a decrease in FEV1 of 20% and an increase in Rsr5 of 40%,
a significant relationship between PD20FEV1 and PDþ40Rrs5
was demonstrated. In FOT, Duiverman et al.38 first
described a strong correlation between PD20FEV1 and
PDþ40Rrs6 in asthmatic children aged 9e16 years. Wilson
et al.28 showed a significant correlation between
PD20PtcO2 and PDþ40Rrs6 in 15 children aged 4e11 years
and a significant correlation between PCþ35Rrs6 and
PCþ15PtcO2 in a subgroup of 18 5-year-old children.
11
Holmgren et al.6 defined a significant bronchial reaction
to histamine as a 50% increase in Rrs FOT based on
a study that included 66 children with bronchial asthma
aged 8e15 years. Our findings confirm the close relationship
between a classical method and the rise in airway resis-
tance in the IOS.
In the present study, in IOS, an increase in Rrs5 of 45%
and a decrease in Xrs5 of 0.69 kPa s L1 revealed the
optimum balance of sensitivity and specificity, detecting
that 70%e80% of children had a significant reaction on
spirometry. These findings are comparable with the results
of Vink et al.,25 who found an area under the ROC of 0.75 to
detect a 20% drop in FEV1 in 19 schoolchildren. Using
a standardised methacholine provocation protocol, an
increase in Rsr5 of 50% in IOS showed the optimal combi-
nation of sensitivity and specificity to detect a 15% reduc-
tion in FEV1 (0.63 and 0.89, respectively). Therefore, an
increase in Rrs5 IOS of 45e50% represents the threshold for
detecting a positive reaction, and thresholds in Rrs5 IOS
might be greater than the thresholds in Rrs6 FOT as sug-
gested by the ATS/ERS statement.23
The Rrs5 IOS and the Rrs6 FOT were closely correlated
(R2 Z 0.83), and the resistance with FOT was smaller than
that with IOS with a difference that increased with
decreasing frequency.24 However, this does not necessarily
mean that the IOS response at a high bronchoconstriction is
unsatisfactory, particularly because the relationship
between Rrs5 IOS and RAW was similar to the relationship
between Rsr6 FOT and RAW (R2 Z 0.52 and R2 Z 0.70,
respectively) (24.). In addition, in young children during
MCTs, both methods, Rrs IOS as well as Xrs IOS, were
significantly sensitive for assessing methacholine-induced
changes in lung function, and both exhibited a frequency
dependency with more profound changes in a lower
frequency domain.14
The study was not designed to compare recurrent
bronchitis, viral-induced wheezing, and allergic asthma.
We chose these different entities because all are known to
produce BHR in young children.
In conclusion, the short MCT protocol using the APS
instrument in combination with a MedicAid nebuliserprovides a feasible method in young children to
measure BHR. Spirometry as the common pulmonary
function test is practicable during bronchial challenges
in this age group. Ninety-five percent of children who
are able to perform reliable spirometries completed the
MCT. A rise in Rsr5 of 45% and a decrease in Xrs5 of
0.69 kPa s L1 showed the optimum balance between
sensitivity and specificity to detect a 20% fall in FEV1.
Changes in Rsr5 slightly preceded changes in FEV1. In
young children who cannot reliably perform spirometric
manoeuvres during MCT, IOS measurements are a prom-
ising alternative.
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